Subtotal: $6,009.00
Subtotal: $6,009.00
$4,999.00 – $13,399.00
Vitrakvi is used as monotherapy to treat adults and children with locally advanced and metastatic neurotrophic tyrosine kinase receptor (NTRK) fusion solid tumors, where surgical resection may lead to severe morbidity and for which there are no adequate treatment options.
Active ingredient: larotrectinib
Prescription medicine
| Формы | 20 Mg Sol, 100 Mg Caps |
|---|
